Predictions
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€3.73
25.04.24
25.04.24
-
25.04.25
25.04.25
0.80%
27.04.24
27.04.24
Risky Investment
aTyr Pharma Inc
Start price
Target price
Perf. (%)
€1.66
14.04.24
14.04.24
-
14.04.25
14.04.25
-13.86%
28.04.24
28.04.24
Could be worthwhile Investment >10% per year
Inotiv Inc.
Start price
Target price
Perf. (%)
€5.50
13.04.24
13.04.24
€4.00
13.04.25
13.04.25
-32.36%
27.04.24
27.04.24
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Little Investments for future growth
SELLAS Life Sciences Group Inc
Start price
Target price
Perf. (%)
€1.06
26.03.24
26.03.24
-
26.03.25
26.03.25
-1.69%
31.03.24
31.03.24
Risky Investment
Bio-Gate AG
Start price
Target price
Perf. (%)
€1.05
03.02.24
03.02.24
-
03.02.25
03.02.25
1.90%
17.02.24
17.02.24
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
PDS Biotechnology Corp.
Start price
Target price
Perf. (%)
€4.08
21.01.24
21.01.24
-
21.01.25
21.01.25
21.10%
03.02.24
03.02.24
Could be worthwhile Investment >10% per year
Palatin Technologies Inc.
Start price
Target price
Perf. (%)
€3.44
20.01.24
20.01.24
€1.00
20.01.25
20.01.25
3.49%
03.02.24
03.02.24
High valuation
Bad rating
Little Investments for future growth
ROE lower than 10% per year
PDS Biotechnology Corp.
Start price
Target price
Perf. (%)
€4.62
07.01.24
07.01.24
-
07.01.25
07.01.25
-11.80%
20.01.24
20.01.24
Could be worthwhile Investment >10% per year
Cellectar BioSciences Inc.
Start price
Target price
Perf. (%)
€2.74
03.01.24
03.01.24
-
03.01.25
03.01.25
-3.65%
06.01.24
06.01.24
Risky Investment
Crossject S.A.
Start price
Target price
Perf. (%)
€4.89
30.12.23
30.12.23
€5.50
30.12.24
30.12.24
-22.39%
10.02.24
10.02.24
Could be worthwhile Investment >10% per year
Bio-Gate AG
Start price
Target price
Perf. (%)
€1.06
26.12.23
26.12.23
-
26.12.24
26.12.24
-8.96%
11.01.24
11.01.24
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
AC Immune Ltd
Start price
Target price
Perf. (%)
€4.16
26.12.23
26.12.23
-
26.12.24
26.12.24
-8.05%
19.01.24
19.01.24
Could be worthwhile Investment >10% per year
Riot Blockchain Inc.
Start price
Target price
Perf. (%)
€13.80
10.12.23
10.12.23
€40.00
10.12.24
10.12.24
-19.13%
26.03.24
26.03.24
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
High Investments for future growth
Very valuable balance sheet
Cellectar BioSciences Inc.
Start price
Target price
Perf. (%)
€2.34
02.12.23
02.12.23
€4.00
31.12.25
31.12.25
12.82%
07.01.24
07.01.24
Could be very worthwhile Investment >20% year
Inotiv Inc.
Start price
Target price
Perf. (%)
€2.46
28.11.23
28.11.23
€0.000
28.11.24
28.11.24
26.83%
09.12.23
09.12.23
Risky Investment
EBIT decline > 20% expected
Decining EBIT margin than peer group
High valuation
Bio-Gate AG
Start price
Target price
Perf. (%)
€0.95
11.11.23
11.11.23
-
11.11.24
11.11.24
-
11.11.23
11.11.23
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Bio-Gate AG
Start price
Target price
Perf. (%)
€0.81
05.11.23
05.11.23
-
05.11.24
05.11.24
15.43%
11.11.23
11.11.23
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Eledon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€2.22
29.10.23
29.10.23
€2.80
30.09.25
30.09.25
-
30.10.23
30.10.23
Could be very worthwhile Investment >20% year
CEL-SCI Corp.
Start price
Target price
Perf. (%)
€1.51
23.10.23
23.10.23
-
23.10.24
23.10.24
-23.18%
28.10.23
28.10.23
Could be worthwhile Investment >10% per year
Inotiv Inc.
Start price
Target price
Perf. (%)
€2.32
16.10.23
16.10.23
-
16.10.24
16.10.24
34.48%
11.12.23
11.12.23
Probably not worthwhile Investment
Eledon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1.28
01.10.23
01.10.23
€2.00
30.09.25
30.09.25
14.84%
29.10.23
29.10.23
Could be very worthwhile Investment >20% year
BioLine RX Ltd ADR
Start price
Target price
Perf. (%)
€1.64
30.09.23
30.09.23
€1.00
30.09.24
30.09.24
-9.76%
14.10.23
14.10.23
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€2.12
27.09.23
27.09.23
-
27.09.24
27.09.24
-35.70%
30.09.23
30.09.23
Risky Investment
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€1.47
26.09.23
26.09.23
-
26.09.24
26.09.24
-26.87%
15.10.23
15.10.23
Could be very worthwhile Investment >20% year
Palatin Technologies Inc.
Start price
Target price
Perf. (%)
€1.81
16.09.23
16.09.23
€1.00
16.09.24
16.09.24
-22.10%
30.09.23
30.09.23
Probably not worthwhile Investment
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
High valuation